Fluoropyrimidine-associated Toxicities in Colorectal Cancer Patients: The Epigenetic Point of View

By  

Clinical Cancer Drugs, Vol. 4, Iss. 2, 2018-01 ,pp. : 93-103

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

By Vincenzi Bruno   Santini Daniele   Russo Antonio   Gavasci Michele   Battistoni Fabrizio   Dicuonzo Giordano   Rocci Laura   Rosaria Valerio Maria   Gebbia Nicola   Tonini Giuseppe  

Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. : 319-327

Future Medicine

Access to resources Recommend Favorite

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

By Thompson Philip A.   O'Brien Susan M.   Wierda William G.   Ferrajoli Alessandra   Stingo Francesco   Smith Susan C.   Burger Jan A.   Estrov Zeev   Jain Nitin   Kantarjian Hagop M.   Keating Michael J.  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3612-3621

Blackwell Publishing

Access to resources Recommend Favorite

Association of surgeon volume and hospital volume with the outcome of patients receiving definitive surgery for colorectal cancer: A nationwide population-based study

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2782-2790

Blackwell Publishing

Access to resources Recommend Favorite

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

By Serdjebi Cindy   Seitz Jean-François   Ciccolini Joseph   Duluc Muriel   Norguet Emmanuelle   Fina Frédéric   Lacarelle Bruno   Ouafik L'Houcine   Dahan Laetitia  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1047-1051

Future Medicine

Access to resources Recommend Favorite